Last news
BioCity Announces Initiation of a Phase 2 Trial for SC0062, a Promising ETA Receptor Antagonist for Chronic Kidney Disease

BioCity Announces Initiation of a Phase 2 Trial for SC0062, a Promising ETA Receptor Antagonist for Chronic Kidney Disease

...

GLOBAL MEDICAL TECHNOLOGY LEADER ZIMMER BIOMET INCREASES PRESENCE IN MALAYSIA WITH A NEW OFFICE AND GBS CENTER

GLOBAL MEDICAL TECHNOLOGY LEADER ZIMMER BIOMET INCREASES PRESENCE IN MALAYSIA WITH A NEW OFFICE AND GBS CENTER

...

European Wellness Signs a Multi-Million MOU for MF3 of Switzerland Supplements & Skincare Exclusivity Distribution for China

European Wellness Signs a Multi-Million MOU for MF3 of Switzerland Supplements & Skincare Exclusivity Distribution for China

...

ESG integration across alternatives continues in spite of refocus on returns

ESG integration across alternatives continues in spite of refocus on returns

...

FXGT.com Adds MetaTrader 4 to its Trading Platform Offering

FXGT.com Adds MetaTrader 4 to its Trading Platform Offering

...

Bright Scholar Filed Annual Report on Form 20-F for Fiscal 2022

Bright Scholar Filed Annual Report on Form 20-F for Fiscal 2022

...

Huntkey Participated in ICTCOMM 2023, Making Further Progress in Vietnam Market

Huntkey Participated in ICTCOMM 2023, Making Further Progress in Vietnam Market

...

Baijiayun Announces Lock-Up Commitment by Certain Shareholders

Baijiayun Announces Lock-Up Commitment by Certain Shareholders

...

menu
menu